<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>83(13)</volume><submitter>van Vliet P</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To study the relation between N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, used as a marker of heart failure in clinical practice, blood pressure (BP), and cognitive decline in the oldest old.&lt;h4>Methods&lt;/h4>In 560 participants of the Leiden 85-plus Study, we measured NT-proBNP levels and BP at age 85 years, at baseline, and global cognitive function (Mini-Mental State Examination [MMSE]) annually during the follow-up of 5 years.&lt;h4>Results&lt;/h4>Subjects in the highest tertile of NT-proBNP levels scored 1.7 points lower on the MMSE at age 85 years than subjects in the lowest tertile (p = 0.004), and had a 0.24-point-steeper decline in MMSE score per year (p = 0.021). The longitudinal association disappeared after full adjustment for possible confounders (0.14-point-steeper decline, p = 0.187). Subjects in the category "highest tertile of NT-proBNP and the lowest tertile of systolic BP" had a 3.7-point-lower MMSE score at baseline (p &lt; 0.001) and a 0.49-point-steeper decline in MMSE score per year (p &lt; 0.001) compared with subjects in the other categories.&lt;h4>Conclusions&lt;/h4>In the oldest old, high NT-proBNP levels are associated with lower MMSE scores. The combination of high NT-proBNP levels and low systolic BP is associated with worst global cognitive function and the steepest cognitive decline. Possibly, a failing pump function of the heart results in lower BP and lower brain perfusion with resultant brain dysfunction.</pubmed_abstract><journal>Neurology</journal><pagination>1192-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4176025</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus Study.</pubmed_title><pmcid>PMC4176025</pmcid><pubmed_authors>Mooijaart SP</pubmed_authors><pubmed_authors>de Ruijter W</pubmed_authors><pubmed_authors>Westendorp RG</pubmed_authors><pubmed_authors>van Vliet P</pubmed_authors><pubmed_authors>Wijsman LW</pubmed_authors><pubmed_authors>Gussekloo J</pubmed_authors><pubmed_authors>de Craen AJ</pubmed_authors><pubmed_authors>Sabayan B</pubmed_authors><pubmed_authors>Poortvliet RK</pubmed_authors></additional><is_claimable>false</is_claimable><name>NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus Study.</name><description>&lt;h4>Objective&lt;/h4>To study the relation between N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, used as a marker of heart failure in clinical practice, blood pressure (BP), and cognitive decline in the oldest old.&lt;h4>Methods&lt;/h4>In 560 participants of the Leiden 85-plus Study, we measured NT-proBNP levels and BP at age 85 years, at baseline, and global cognitive function (Mini-Mental State Examination [MMSE]) annually during the follow-up of 5 years.&lt;h4>Results&lt;/h4>Subjects in the highest tertile of NT-proBNP levels scored 1.7 points lower on the MMSE at age 85 years than subjects in the lowest tertile (p = 0.004), and had a 0.24-point-steeper decline in MMSE score per year (p = 0.021). The longitudinal association disappeared after full adjustment for possible confounders (0.14-point-steeper decline, p = 0.187). Subjects in the category "highest tertile of NT-proBNP and the lowest tertile of systolic BP" had a 3.7-point-lower MMSE score at baseline (p &lt; 0.001) and a 0.49-point-steeper decline in MMSE score per year (p &lt; 0.001) compared with subjects in the other categories.&lt;h4>Conclusions&lt;/h4>In the oldest old, high NT-proBNP levels are associated with lower MMSE scores. The combination of high NT-proBNP levels and low systolic BP is associated with worst global cognitive function and the steepest cognitive decline. Possibly, a failing pump function of the heart results in lower BP and lower brain perfusion with resultant brain dysfunction.</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Sep</publication><modification>2021-02-20T21:55:16Z</modification><creation>2019-03-27T01:36:30Z</creation></dates><accession>S-EPMC4176025</accession><cross_references><pubmed>25142900</pubmed><doi>10.1212/wnl.0000000000000820</doi><doi>10.1212/WNL.0000000000000820</doi></cross_references></HashMap>